# Post Operative Pain Management Through Adductor Canal Block With Bupivacaine for ACL Reconstruction

> **NCT05161221** · PHASE3 · UNKNOWN · sponsor: **Rothman Institute Orthopaedics** · enrollment: 154 (estimated)

## Conditions studied

- Pain, Postoperative
- ACL

## Interventions

- **DRUG:** OxyCODONE 5 mg Oral Tablet
- **DRUG:** Naproxen 500 Mg
- **DRUG:** Tylenol Pill
- **DRUG:** Liposomal bupivacaine
- **PROCEDURE:** Femoral Nerve Catheter

## Key facts

- **NCT ID:** NCT05161221
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-06
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161221, "Post Operative Pain Management Through Adductor Canal Block With Bupivacaine for ACL Reconstruction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05161221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*